2026 Keynote Preview with Dr. Michael Giacomelli

Most of our focus for the last few years has been skin cancer because it's such a huge application.

And it just you don't think of it as like a tremendously dangerous disease aside from the few melanoma cases.

But it's just such a huge impact because millions of people are treated every year for skin cancer.

Um, so there's

just a huge opportunity.

It's a huge, um, it's a huge use of, of histopathology actually is just going through these millions and millions of biopsies, these millions and

millions

of excisions.

Cause I mean, I, even I've had something cut off of my skin.

Everybody does.

And when you get something cut out, it goes to the path lab and somebody has to look at it.

Decisions have to be made.

And for the most part it's benign or it's not, not actionable.

Right.

But somebody still looks at it.

So the, The labs are just doing millions and millions

of these

excisions every year.

So we were just very interested in that application.

We've looked at other things, too.

We did some work in prostate surgery, some work in breast surgery.

And now we're also interested in things like head and neck cancer, too.

There's all sorts of applications, of course, of surgical pathology and biopsies, pathology, things like that.

But yeah, most of our recent work has been in Mohs surgery and dermatology.